Antonio Vitale, Francesca Della Casa, Silvana Guerriero, Gaafar Ragab, Angela Mauro, Valeria Caggiano, Marco Cattalini, Emanuela Del Giudice, Rossella Favale, Carla Gaggiano, Irene Bellicini, Maria Pia Paroli, Mohamed Tharwat Hegazy, Jurgen Sota, Abdurrahman Tufan, Alberto Balistreri, Ibrahim Almaghlouth, Francesco La Torre, Ewa Więsik-Szewczyk, Maria Tarsia, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, Bruno Frediani, Gian Marco Tosi, Alex Fonollosa, José Hernández-Rodríguez, Rana Hussein Amin, Giuseppe Lopalco, Donato Rigante, Luca Cantarini, Claudia Fabiani
INTRODUCTION: Scientific evidence of the effectiveness of the tumor necrosis factor inhibitor adalimumab (ADA) in pediatric patients with non-infectious non-anterior uveitis is still limited. The aim of this study is to investigate the therapeutic role of ADA in a cohort of pediatric patients with non-anterior uveitis. METHODS: This is an international multicenter study analyzing real-life data referred to pediatric patients treated with ADA for intermediate uveitis/pars planitis, posterior uveitis and panuveitis...
August 2023: Ophthalmology and Therapy